Finance

Lists
300519:SHE
Zhejiang Xinguang Pharmaceutical Co Ltd
CNÂ¥14.75
-1.21%
(-0.18) 1D
Aug 28, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300519...
Open
CNÂ¥14.91
High
CNÂ¥15.32
Low
CNÂ¥14.69
Mkt. cap
2.36B
Avg. vol.
6.96M
Volume
6.23M
Dividend
2.03%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
May 29, 2026
P/E ratio
38.05
52-wk high
CNÂ¥18.25
52-wk low
CNÂ¥11.53
EPS
CNÂ¥0.39
Shares outstanding
160.00M
No. of employees
309
Open
CNÂ¥14.91
High
CNÂ¥15.32
Low
CNÂ¥14.69
Mkt. cap
2.36B
Avg. vol.
6.96M
Volume
6.23M
Dividend
2.03%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
May 29, 2026
P/E ratio
38.05
52-wk high
CNÂ¥18.25
52-wk low
CNÂ¥11.53
EPS
CNÂ¥0.39
Shares outstanding
160.00M
No. of employees
309
About Zhejiang Xinguang Pharmaceutical Co Ltd
CEO-
Employees309
FoundedNov 18, 1998
Headquarters-
SectorPharmaceutical industry
Websitexgpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
64.68M
59.74M
88.47M
54.12M
Cost of goods sold
35.60M
37.97M
48.33M
28.57M
Cost of revenue
35.60M
37.97M
48.33M
28.57M
Research and development expenses
3.06M
3.31M
2.83M
4.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.41M
10.76M
8.04M
8.64M
Operating expense
10.29M
16.44M
11.75M
13.53M
Total operating expenses
45.89M
54.41M
60.08M
42.11M
Operating income
18.79M
5.33M
28.39M
12.01M
Other non operating income
-2.36K
-2.56K
-3.00K
1.28M
EBT including unusual items
17.29M
9.86M
30.47M
14.99M
EBT excluding unusual items
19.90M
8.11M
30.36M
14.86M
Income tax expense
3.86M
980.05K
4.10M
1.64M
Effective tax rate
22.32%
9.94%
13.46%
10.97%
Other operating expenses
-251.59K
2.61M
1.04M
679.85K
Net income
13.43M
8.88M
26.37M
13.34M
Net profit margin
20.76%
14.86%
29.80%
24.65%
Earnings per share
-
-
-
-
Interest and investment income
1.12M
2.79M
1.98M
1.56M
Interest expense
-
-
-
-
Net interest expenses
1.12M
2.79M
1.98M
1.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
22.52M
9.01M
32.07M
15.46M
Gain or loss from assets sale
-3.72K
3.72K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps